SYNCOMF19.23

Syncom Formulations (India) Limited

· Pharma & Health
₹ CrorePeersHESTERBIONGLFINEWINDLASJAGSNPHARMAMRUTANJANINDOCOSAIPARENTMcap ₹1,808 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SYNCOMF
FY26
HESTERBIO
FY26
NGLFINE
FY26
WINDLAS
FY26
Peer
Median
Valuation — at last close
P/E23.74×33.59×34.67×35.92×34.67× -32%
P/B4.36×5.25×5.07×4.12×5.07× -14%
EV/EBITDA21.92×24.42×23.87×20.59×23.87× -8%
Market Cap₹1,808 Cr₹1,931 Cr₹1,669 Cr₹2,396 Cr₹1,931 Cr -6%
Growth
Revenue CAGR 3Y29.69%7.72%21.68%20.78%20.78% +43%
Revenue CAGR 5Y9.19%9.19%
Net Income CAGR 3Y56.16%27.04%32.91%15.95%27.04% +108%
Revenue YoY (latest Q)7.38%-8.16%33.57%17.66%17.66% -58%
Net Income YoY (latest Q)57.71%459.27%99.09%-1.79%99.09% -42%
Profitability
EBITDA Margin15.83%26.05%14.51%11.59%14.51% +9%
Net Income Margin15.63%17.28%9.61%7.35%9.61% +63%
Return on Common Equity18.42%15.13%14.62%11.44%14.62% +26%
Return on Capital Employed16.48%12.90%13.43%12.62%12.90% +28%
Return on Assets14.32%8.48%8.82%7.32%8.48% +69%
Credit & Quality
Total Debt/Equity0.00×0.51×0.33×0.05×0.33× -100%
Interest Coverage61.38×6.20×11.89×15.33×11.89× +416%
Scale — latest FY
Revenue / Total Income₹489 Cr₹333 Cr₹501 Cr₹904 Cr₹501 Cr -2%
Net Income₹76.4 Cr₹57.5 Cr₹48.1 Cr₹66.5 Cr₹57.5 Cr +33%
Total Assets₹534 Cr₹678 Cr₹545 Cr₹907 Cr₹678 Cr -21%
EPS₹0.81₹67.57₹77.9₹31.6₹67.57 -99%
Book Value per Share₹4.41₹432.34₹532.91₹275.2₹432.34 -99%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.